Amanda Pollard advises technology and life sciences companies at all stages of growth. She also represents financial and strategic investors in equity investments in high-growth companies.
Amanda’s practice focuses on corporate and securities law, including company formation, founder and employee equity issuances, corporate governance, venture capital financings, secondary sale transactions, initial public offerings, mergers and acquisitions, and other strategic transactions. Amanda leverages her experience in the firm’s London office to advise U.S., UK and European companies and investors on cross-border transactions.
LinkedIn
